Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 HER2-positive Breast Cancer 4 Salivary Gland Neoplasms 1 HER2-positive Advanced Breast Cancer 1

Interventions

pyrotinib 1 Vinorelbine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × HER2-positive Advanced Breast Cancer × pyrotinib × Clear all

NCT05856383 2023-05-12

HER2-VIP

Zhejiang Cancer Hospital

HER2-positive Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡